Vyaire Medical Inc. Assigned 'B-' Rating, Outlook Stable; Debt Ratings Assigned - S&P Global Ratings’ Credit Research

Vyaire Medical Inc. Assigned 'B-' Rating, Outlook Stable; Debt Ratings Assigned

Vyaire Medical Inc. Assigned 'B-' Rating, Outlook Stable; Debt Ratings Assigned - S&P Global Ratings’ Credit Research
Vyaire Medical Inc. Assigned 'B-' Rating, Outlook Stable; Debt Ratings Assigned
Published Mar 19, 2018
4 pages (1525 words) — Published Mar 19, 2018
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

Vyaire Medical Inc., a Mettawa, Ill.-based manufacturer and distributor of respiratory equipment and supplies, is recapitalizing following the acquisition by private equity company Apax Partners of the remaining 49.9% equity interest in Vyaire owned by Becton Dickinson&Co. The new capital structure will include a US$125 million revolver (undrawn at closing, and which steps down to $85 million after one year), a US$360 million first-lien term loan, and a €75 million second-lien term loan. We expect adjusted debt leverage to be about 7.8x for 2018, and improve to about 7x for 2019. We are assigning a 'B-' corporate credit rating to the company. The outlook is stable. We are also assigning a 'B-' issue-level rating and '3' recovery rating

  
Brief Excerpt:

...+ Vyaire Medical Inc., a Mettawa, Ill.-based manufacturer and distributor of respiratory equipment and supplies, is recapitalizing following the acquisition by private equity company Apax Partners of the remaining 49.9% equity interest in Vyaire owned by Becton Dickinson & Co. + The new capital structure will include a US$125 million revolver (undrawn at closing, and which steps down to $85 million after one year), a US$360 million first-lien term loan, and a 75 million second-lien term loan. We expect adjusted debt leverage to be about 7.8x for 2018, and improve to about 7x for 2019. + We are assigning a 'B-' corporate credit rating to the company. The outlook is stable. + We are also assigning a 'B-' issue-level rating and '3' recovery rating to the first-lien debt. We are assigning a '###' issue-level rating and '6' recovery rating to the second-lien debt. + The stable rating outlook reflects our base-case forecast for modest organic revenue growth and EBITDA margin expansion, and for...

  
Report Type:

Ratings Action

Issuer
Sector
Global Issuers
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Vyaire Medical Inc. Assigned 'B-' Rating, Outlook Stable; Debt Ratings Assigned" Mar 19, 2018. Alacra Store. May 20, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Vyaire-Medical-Inc-Assigned-B-Rating-Outlook-Stable-Debt-Ratings-Assigned-2008581>
  
APA:
S&P Global Ratings’ Credit Research. (). Vyaire Medical Inc. Assigned 'B-' Rating, Outlook Stable; Debt Ratings Assigned Mar 19, 2018. New York, NY: Alacra Store. Retrieved May 20, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Vyaire-Medical-Inc-Assigned-B-Rating-Outlook-Stable-Debt-Ratings-Assigned-2008581>
  
US$ 150.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.